Abstract:Background People with metabolic syndrome are at higher risk for developing coronary artery disease (CAD). The effect of the metabolic syndrome on outcomes in patients with preexisting CAD has not been well studied. This study was conducted to assess the prevalence, characteristics, in hospital and long term prognosis of CAD with metabolic syndrome and to determine the factors influencing the prognosis of the disease.Methods The DESIRE registry contains data of 3696 patients with CAD between 2001 and 2004. Mean long term followup was (829 +/- 373) days. Diagnosis of metabolic syndrome was based on modified International Diabetes Federation (IDF) Worldwide Definition of the Metabolic Syndrome, using body mass index (BMI) instead of waist circumference.Results Of 2596 patients with complete records of height, weight, and so on, 1280 (49.3%) were identified with metabolic syndrome. The patients with metabolic syndrome had higher level of body mass index, systolic blood pressure, diastolic blood pressure, fasting glucose and disordered blood lipid (all P < 0.0001), with higher creatinine [(10.5 +/- 4.3) mg/L vs (9.9 +/- 2.9) mg/L, P < 0.0001] and the number of white blood cells [(7.49 +/- 2.86) X109/Lvs(7.19 +/- 2.62) X 109/L, P=0.008) compared with those without metabolic syndrome. The patients with metabolic syndrome showed severer coronary angiographic alterations (left main artery and/or > 2-vessel) (73.6% vs 69.6%, P=0.031). There were no significant differences of major adverse cardiac and cerebral events (MACCE) or mortality in hospital between the two groups. During followup, the ratio of MACCE in CAD with metabolic syndrome patients increased significantly (11.8% vs 10.0%, P=0.044). Fasting blood glucose (> ,1000 mg/L) and triglyceride (TQ >, 1500 mg/L) were responsible for most of the increased risk associated with the metabolic syndrome (adjusted OR 1.465, 95% CI 1.037-1.874, P=0.032; OR 1.378, 95% CI 1.014-1.768, P=0.044).Conclusions The prevalence of metabolic syndrome was very high in CAD patients. The metabolic syndrome confers a higher risk of long term MACCE in patients with CAD, and dysglycaemia and hypertriglycaemia appear to be responsible for most of the associated risk.

Risk of Major Adverse Cardiovascular Events in Patients with Metabolic Syndrome after Revascularization: A Meta-Analysis of Eighteen Cohorts with 18457 Patients

The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome.

Impact of metabolic syndrome on short-term outcome of carotid revascularization: a large sample size study in Chinese population

E0376 Effect of Metabolic Syndrome on Prognosis of Revascularization in Patients with Coronary Artery Disease

Effect of Metabolic Syndrome on Prognosis and Clinical Characteristics of Revascularization in Patients with Coronary Artery Disease.

Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis

The association between metabolic syndrome and major adverse cardiac and cerebrovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Association Between Metabolic Syndrome and Outcomes of Large-Artery Atherosclerosis Stroke Treated with Reperfusion Therapy

Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention

The Prognosis of Coronary Disease with Different Cardiovascular Risk Factors Combined

Metabolic syndrome and its individual components with mortality among patients with coronary heart disease

Prognosis of Metabolic Syndrome in Coronary Artery Disease Patients of Different Genders

Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease

Patients with Metabolic Syndrome Have a Greater Rate of Complications after Arthroplasty A SYSTEMATIC REVIEW AND META-ANALYSIS

Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis

Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies.

Patients with metabolic syndrome have a greater rate of complications after arthroplasty

The Metabolic Score for Insulin Resistance in the Prediction of Major Adverse Cardiovascular Events in Patients after Coronary Artery Bypass Surgery: a Multicenter Retrospective Cohort Study

An updated meta-analysis of optimal medical therapy with or without invasive therapy in patients with stable coronary artery disease

Impact of Isolated Coronary Microvascular Disease Diagnosed Using Various Measurement Modalities on Prognosis: An Updated Systematic Review and Meta-Analysis.

Impact of Metabolic Syndrome on the Prognosis of Patients with Acute Myocardial Infarction Accepting Thrombolytic Therapy